Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4831 to 4845 of 8314 results

  1. Factors that may influence the use of nicotine replacement therapy and e-cigarettes: Which factors may prevent people who currently smoke tobacco from using other forms of nicotine such as NRT and nicotine-containing e‑cigarettes? Does this vary according to population group, particularly among under-served groups?

    Recommendation ID NG209/10 Question Factors that may influence the use of nicotine replacement therapy and e-cigarettes: Which factors

    Research recommendation
    Published
    17 December 2021

  2. Adjuvant bisphosphonate therapy:- Which groups of people with early and locally advanced breast cancer would benefit from the use of adjuvant bisphosphonates?

    Recommendation ID NG101/2 Question Adjuvant bisphosphonate therapy:- Which groups of people with early and locally advanced breast cancer

    Research recommendation
    Published
    11 December 2018

  3. Which interventions for other communicable diseases could be used to encourage people at increased risk of hepatitis B and C infection to take up the offer of testing and treatment?

    Recommendation ID PH43/8 Question Which interventions for other communicable diseases could be used to encourage people at increased risk

    Research recommendation
    Published
    9 June 2015

  4. Interventions to improve CPAP adherence: Which interventions, including behavioural interventions, are most clinically and cost effective to improve adherence to CPAP in people with OSAHS, obesity hypoventilation syndrome (OHS) and COPD–OSAHS (chronic obstructive pulmonary disease–OSAHS) overlap syndrome who have difficulty using CPAP?

    Recommendation ID NG202/3 Question Interventions to improve CPAP adherence: Which interventions, including behavioural interventions, are

    Research recommendation
    Published
    30 September 2021

  5. Core outcomes for study reporting: Which mental wellbeing and productivity outcomes should be used in a core outcome set for research into workplace mental wellbeing?

    Recommendation ID NG212/05 Question Core outcomes for study reporting: Which mental wellbeing and productivity outcomes should be used

    Research recommendation
    Published
    8 April 2022

  6. Which new (previously not researched) primary prevention interventions (that do not include information provision as a component) are effective and cost effective in preventing skin cancer in the UK? What factors influence effectiveness and cost effectiveness?

    Recommendation ID PH32/3 Question Which new (previously not researched) primary prevention interventions (that do not include information

    Research recommendation
    Published
    9 June 2015

  7. Which participatory approaches are most effective and cost effective among populations at higher risk of type 2 diabetes? This should consider the awareness, knowledge, understanding and skills of the providers of interventions for people at high risk of developing type 2 diabetes?

    Recommendation ID PH35/3 Question Which participatory approaches are most effective and cost effective among populations at higher risk

    Research recommendation
    Published
    9 June 2015

  8. Same-day hospital specialist assessment: Which people with extreme hypertension (220/120 mmHg or higher) or emergency symptoms should be referred for same-day hospital specialist assessment?

    Recommendation ID NG136/06 Question Same-day hospital specialist assessment: Which people with extreme hypertension (220/120 mmHg or higher)

    Research recommendation
    Published
    11 April 2022

  9. Primary care-led assessment models:- Which primary care-led models of assessment of people with a suspected medical emergency in the community, such as GP home visits, are most clinically and cost effective? [See the evidence review on GP-led home visits.]

    Recommendation ID NG94/8 Question Primary care-led assessment models:- Which primary care-led models of assessment of people with a suspected

    Research recommendation
    Published
    15 November 2018

  10. Signs and symptoms of Kawasaki disease: Which signs and symptoms (or combinations of signs and symptoms) predict a diagnosis of Kawasaki disease in children under 5 presenting with fever lasting 5 days or more?

    Recommendation ID NG143/08 Question Signs and symptoms of Kawasaki disease: Which signs and symptoms (or combinations of signs and symptoms)

    Research recommendation
    Published
    17 December 2021

  11. What is the effectiveness, cost effectiveness and acceptability of the whole family approach to carers' assessments?

    Recommendation ID NG150/1 Question What is the effectiveness, cost effectiveness and acceptability of the whole family approach to carers'

    Research recommendation
    Published
    10 February 2020

  12. What is the efficacy and cost effectiveness of rehabilitation services compared with treatment as usual for people with complex psychosis with residual disability, who are leaving early intervention services?

    Recommendation ID NG181/1 Question What is the efficacy and cost effectiveness of rehabilitation services compared with treatment as usual

    Research recommendation
    Published
    26 October 2020

  13. Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic assessment and intervention for people living with high levels of multimorbidity?

    Recommendation ID NG56/2 Question Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic

    Research recommendation
    Published
    18 October 2016

  14. Women with breast cancer:- What is the safety and effectiveness of alternatives to systemic HRT as treatments for menopausal symptoms in women who have had treatment for breast cancer?

    Recommendation ID NG23/1 Question Women with breast cancer:- What is the safety and effectiveness of alternatives to systemic HRT as treatments

    Research recommendation
    Published
    11 December 2015

  15. What is the effectiveness and cost effectiveness of different scheduling of zoledronic acid in the prevention and reduction of skeletal events in people with hormone-refractory prostate cancer?

    Recommendation ID NG131/8 Question What is the effectiveness and cost effectiveness of different scheduling of zoledronic acid in the prevention

    Research recommendation
    Published
    25 October 2019